Erythrodermic psoriasis: pathophysiology and current treatment perspectives

Rasnik K Singh1 Department of Medicine, University of California – Los Angeles, David Geffen School of Medicine, Los AngelesCorrespondence[email protected]

Kristina M Lee2 Department of Dermatology, University of California – San Francisco, San Francisco

Derya Ucmak2 Department of Dermatology, University of California – San Francisco, San Francisco

Merrick Brodsky3 Department of Medicine, University of California – Irvine, School of Medicine, Irvine, CA

Zaza Atanelov4 Department of Medicine, New York Medical College, Valhalla, NY

Benjamin Farahnik5 Department of Medicine, University of Vermont College of Medicine, Burlington, VT

Michael Abrouk3 Department of Medicine, University of California – Irvine, School of Medicine, Irvine, CA

Mio Nakamura2 Department of Dermatology, University of California – San Francisco, San Francisco

Tian Hao Zhu6 Department of Medicine, University of Southern California Keck School of Medicine, Los Angeles, CA, USA

Wilson Liao2 Department of Dermatology, University of California – San Francisco, San Francisco

show all

Erythrodermic psoriasis: pathophysiology and current treatment perspectives

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Erythrodermic psoriasis: pathophysiology and current treatment perspectives

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date